COMPREHENSIVE APPROACH TO THE TREATMENT OF TUBO-PERITONEAL INFERTILITY IN WOMEN WITH COMBINED VULVOVAGINAL AND CERVICAL INFECTIONS

Authors

DOI:

https://doi.org/10.11603/24116-4944.2025.1.15407

Keywords:

infertility, vulvovaginal infections, cervical infections, diagnosis, treatment optimization, reproductive function, ozone therapy

Abstract

The aim of the study – to assess the impact of urogenital infections on female reproductive function and to develop an effective, individualized treatment algorithm incorporating ozone therapy as a promising adjuvant method.

Materials and Methods. The study involved 150 women of reproductive age diagnosed with infertility (both primary and secondary forms). All participants underwent comprehensive clinical, instrumental, microbiological, and immunological examinations. The main group consisted of 75 women who, in addition to standard treatment, received ozone therapy (vaginal instillations and ozone-oxygen infusions), while the control group of 75 patients received only conventional antibacterial and anti-inflammatory therapy.

Results and Discussion. Analysis of the results demonstrated that the inclusion of ozone therapy led to a significant improvement in clinical outcomes: the pregnancy rate within six months after treatment was 47 % in the main group versus 18 % in the control group, reflecting a 2.6-fold increase in treatment effectiveness (p<0.01). Furthermore, normalization of the vaginal microbiota, reduction in pro-inflammatory cytokine levels, and improvement in local immune parameters were observed.

Conclusions. These findings confirm the clinical value of incorporating ozone therapy into comprehensive treatment protocols for infection-related infertility as an effective and pathogenetically justified therapeutic component capable of significantly improving reproductive outcomes.

Author Biographies

O. V. Gorbunova, Shupyk National Healthсare University of Ukraine

MD, PhD, DSc, Professor, Department of Obstetrics, Gynecology and Perinatology

S. V. Nahirniak, Shupyk National Healthсare University of Ukraine

MD, PhD-student

References

Leli, C., Mencacci, A., Latino, M.A., & Clerici, P. (2018). Mycoplasma hominis and Mycoplasma genitalium in childbearing age women by a commercially available multiplex real-time PCR: An Italian observational multicentre study. Journal of Infection and Public Health, 11(5), 713-718. DOI: 10.1016/j.jiph.2018.04.002. DOI: https://doi.org/10.1016/j.jiph.2018.04.002

Ravel, J., & Simón, C. (2021). Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. American Journal of Obstetrics and Gynecology, 224(1), 22-29. DOI: 10.1016/j.ajog.2020.08.101. DOI: https://doi.org/10.1016/j.ajog.2020.10.019

Busnelli, A., Garolla, A., Tersigni, C., Parodi V., Inversetti, A. Levi-Setti, P.E. ... & Di Simone, N. (2023). Sperm human papillomavirus infection and risk of idiopathic recurrent pregnancy loss: Insights from a multicenter case-control study. Fertility and Sterility, 119(2), 378-386. DOI: 10.1016/j.fertnstert.2022.10.014. DOI: https://doi.org/10.1016/j.fertnstert.2022.12.002

Wójkowska-Mach, J., Pomorska-Wesołowska, M., Romanik M., & Romaniszyn, D. (2021). Prevalence and antimicrobial susceptibility profiles of microorganisms associated with lower reproductive tract infections in women. International Journal of Environmental Research and Public Health, 18(1), 335. DOI: 10.3390/ijerph18010335. DOI: https://doi.org/10.3390/ijerph18010335

Yazdy, G.M., Van Gerwen, O.T., Ghanem, K.G., Sobel, J.D., Tuddenham, S., & Muzny, C.A. (2023). Testing for Mycoplasma genitalium in women with vaginal symptoms should not be performed routinely. Sexually Transmitted Diseases, 50(10), 707-711. DOI: 10.1097/OLQ.0000000000001837. DOI: https://doi.org/10.1097/OLQ.0000000000001849

Zhang, Z., Zong, X., Bai, H., Fan, L., Li, T., & Liu, Zh. (2023). Prevalence of Mycoplasma genitalium and Chlamydia trachomatis in Chinese female with lower reproductive tract infection: A multicenter epidemiological survey. BMC Infectious Diseases, 23(1), 25. DOI: 10.1186/s12879-022-07922-4. DOI: https://doi.org/10.1186/s12879-022-07975-2

Peuchant, O., Lhomme, E., Krêt, M., Ghezzoul, B., Roussillon, C. Bébéar, C., ... & de Barbeyrac, B. (2019). Randomized, open-label, multicenter study of azithromycin compared with doxycycline for treating anorectal Chlamydia trachomatis infection. Medicine (Baltimore), 98(7), e14402. DOI: 10.1097/MD.0000000000014402. DOI: https://doi.org/10.1097/MD.0000000000014572

Ma, C., Du, J., Dou, Y., Chen, R., Li, Y., Zhao, L., ... & Zhang, K. (2021). The associations of genital mycoplasmas with female infertility and adverse pregnancy outcomes: A systematic review and meta-analysis. Journal of Assisted Reproduction and Genetics, 38(1), 35-49. DOI: 10.1007/s10815-020-01974-z.

Cao, D.Y., Yang, J.X., Wu, X.H., Chen, Y.L., Li, L., Liu, K.J., ...& Shen, K. (2013). Comparisons of vaginal and abdominal radical trachelectomy for early-stage cervical cancer: Preliminary results of a multi-center research in China. British Journal of Cancer, 109(11), 2904-2910. DOI: 10.1038/bjc.2013.654. DOI: https://doi.org/10.1038/bjc.2013.654

Slama, J., Runnebaum, I.B., Scambia, G., Angeles, M.A., Bahrehmand, K., Kommoss, S., ... & Cibula, D. (2023). Analysis of risk factors for recurrence in cervical cancer patients after fertility-sparing treatment. American Journal of Obstetrics and Gynecology, 229(2), 1-9. DOI: 10.1016/j.ajog.2023.01.014. DOI: https://doi.org/10.1016/j.ajog.2022.11.1295

Published

2025-05-28

How to Cite

Gorbunova, O. V., & Nahirniak, S. V. (2025). COMPREHENSIVE APPROACH TO THE TREATMENT OF TUBO-PERITONEAL INFERTILITY IN WOMEN WITH COMBINED VULVOVAGINAL AND CERVICAL INFECTIONS. Actual Problems of Pediatrics, Obstetrics and Gynecology, (1), 44–47. https://doi.org/10.11603/24116-4944.2025.1.15407

Issue

Section

OBSTETRICS AND GYNECOLOGY